» Articles » PMID: 21160629

Toxic Megacolon Associated Clostridium Difficile Colitis

Overview
Date 2010 Dec 17
PMID 21160629
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Toxic megacolon is a severe complication of Clostridium difficile (C. difficile) colitis. As the prevalence of C. difficile colitis increases and treatments become more refractory, clinicians will encounter more patients with C. difficile associated toxic megacolon in the future. Here, we review a case of toxic megacolon secondary to C. difficile colitis and review the current literature on diagnosis and management. We identify both clinical and radiologic criteria for diagnosis and discuss both medical and surgical options for management. Ultimately, we recommend using the Jalen criteria in conjunction with daily abdominal radiographs to help establish the diagnosis of toxic megacolon and to make appropriate treatment recommendations. Aggressive medical management using supportive measures and antibiotics should remain the mainstay of treatment. Surgical intervention should be considered if the patient does not clinically improve within 2-3 d of initial treatment.

Citing Articles

From Hemorrhage to Diarrhea: The Comprehensive Clinical Journey of a Patient With Pseudomembranous Colitis.

Nilofar F, Babu N, Kumar M, Palanisamy S, T G Cureus. 2024; 16(7):e65176.

PMID: 39176325 PMC: 11339720. DOI: 10.7759/cureus.65176.


Retrospective Analysis of Infection Rates and Outcomes in Hospitalized Patients during the COVID-19 Pandemic: A Unicenter Study in Reus, Spain.

Iftimie S, Lopez-Azcona A, Corchero-Valverde M, Peralta-Vazquez A, Lopez-Cordon L, Garcia-Cervera C J Clin Med. 2024; 13(10).

PMID: 38792341 PMC: 11122305. DOI: 10.3390/jcm13102799.


Clostridioides Difficile: A Concise Review of Best Practices and Updates.

Yakout A, Bi Y, Harris D J Prim Care Community Health. 2024; 15:21501319241249645.

PMID: 38726585 PMC: 11085020. DOI: 10.1177/21501319241249645.


Clinical outcomes of clostridioides difficile infection in the very elderly.

Kassem S, Hijazi N, Stein N, Zaina A, Ganaim M Intern Emerg Med. 2024; 19(4):1041-1049.

PMID: 38615301 PMC: 11186863. DOI: 10.1007/s11739-024-03580-0.


CSPG4-dependent cytotoxicity for TcdB is influenced by extracellular calcium and chondroitin sulfate.

Doyle D, DeAngelis P, Ballard J mSphere. 2024; 9(4):e0009424.

PMID: 38470254 PMC: 11036797. DOI: 10.1128/msphere.00094-24.


References
1.
Koss K, Clark M, Sanders D, Morton D, Keighley M, Goh J . The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis. 2006; 8(2):149-54. DOI: 10.1111/j.1463-1318.2005.00876.x. View

2.
Miller A, Tabrizian P, Greenstein A, Dikman A, Byrn J, Divino C . Long-term follow-up of patients with fulminant Clostridium difficile colitis. J Gastrointest Surg. 2009; 13(5):956-9. DOI: 10.1007/s11605-009-0819-5. View

3.
Indra A, Schmid D, Huhulescu S, Hell M, Gattringer R, Hasenberger P . Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007. J Med Microbiol. 2008; 57(Pt 6):702-708. DOI: 10.1099/jmm.0.47476-0. View

4.
Byrn J, Maun D, Gingold D, Baril D, Ozao J, Divino C . Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008; 143(2):150-4. DOI: 10.1001/archsurg.2007.46. View

5.
Barbut F, Gariazzo B, Bonne L, Lalande V, Burghoffer B, Luiuz R . Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol. 2007; 28(2):131-9. DOI: 10.1086/511794. View